Cardiovascular effects of diethylcarbamazine citrate
A global programme for the elimination of LF has been launched employing mass drug administration (MDA) of annual single dose of a combination of diethylcarbamazine citrate
(DEC)/ ivermectin and albendazole (2,3).
announced today that it has received prequalification from the World Health Organization (WHO) for diethylcarbamazine citrate
(DEC) 100 mg tablets manufactured at its Vizag Plant in India for the treatment of lymphatic filariasis, a neglected tropical disease (NTD).
Tenders are invited for Procurement of Diethylcarbamazine Citrate
100mg (DEC) Tablet, Quantity-300
USAID support includes funding for annual community- and school-based distribution of two drugs diethylcarbamazine citrate
and albendazole to over 4.
Tenders are invited for Tablet Diethylcarbamazine Citrate
100 Mg In Strip